date/time interval
- October 1, 2021 - September 30, 2024
Restoring lymphoma immunosurveillance by combined EZH2 inhibition and immunotherapy.
Grant
Overview
awarded by
administered by
sponsor award ID
- LLS 6643-22
Affiliation
contributor
- Beguelin, Wendy Key Personnel 2021 - 2024
- Zappasodi, Roberta Principal Investigator 2021 - 2024